Milestone Pharmaceuticals
MIST
MIST
47 hedge funds and large institutions have $203M invested in Milestone Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
5.49% more ownership
Funds ownership: 69.58% → 75.07% (+5.5%)
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
Holders
47
Holding in Top 10
3
Calls
$11.6M
Puts
$9.09M
Top Buyers
| 1 | +$18.4M | |
| 2 | +$8.5M | |
| 3 | +$5.12M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$4.81M |
| 5 |
LPC
Lion Point Capital
New York
|
+$4.62M |
Top Sellers
| 1 | -$11.7M | |
| 2 | -$4.02M | |
| 3 | -$3.97M | |
| 4 |
Millennium Management
New York
|
-$3.23M |
| 5 |
PVI
Pura Vida Investments
New York
|
-$2.96M |